Pneumonia Testing Market by Type, Method, Technology, End-user

List of Tables

The Pneumonia Testing Market is projected to reach USD 2.28 billion by 2030 from USD 1.41 billion in 2022, at a CAGR of 6.17% during the forecast period.

Global Pneumonia Testing Market

KEY MARKET STATISTICS
Base Year Value [2022]	USD 1.41 billion
Estimated Year Value [2023]	USD 1.49 billion
Forecast Year Value [2030]	USD 2.28 billion
CAGR (%)	6.17%

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Pneumonia Testing Market.

Based on Type, market is studied across Instruments and Reagents & Consumables. The Instruments is projected to witness significant market share during forecast period.

Based on Method, market is studied across Immunodiagnostics, Molecular Diagnostics, and Point of Care Testing. The Point of Care Testing is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Enzyme Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry, Polymerase Chain Reaction, and Western Blot. The Immunohistochemistry is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Diagnostic Laboratories and Hospitals & Clinics. The Diagnostic Laboratories is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Pneumonia Testing Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Pneumonia Testing Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Pneumonia Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Curetis GmbH, Danaher Corporation, DiaSorin S.p.A., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Hain Lifescience GmbH by Bruker Corporation, Hologic, Inc., Intec Products, Inc., Luminex Corporation, Meridian Bioscience, Inc., OpGen Inc., QIAGEN N.V., Quest Diagnostics Incorporated, Quidel Corporation, Sekisui Diagnostics, LLC, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and True Bearing Diagnostics, Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Pneumonia Testing Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Pneumonia Testing Market?

3. What is the competitive strategic window for identifying opportunities in the Pneumonia Testing Market?

4. What are the latest technology trends and regulatory frameworks in the Pneumonia Testing Market?

5. What is the market share of the leading vendors in the Pneumonia Testing Market?

6. Which modes and strategic moves are suitable for entering the Pneumonia Testing Market?

Product Code: MRR-69324464D11E

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Pneumonia Testing Market, by Region

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing prevalence of pneumonia with expanding geriatric population worldwide
  - 5.1.1.2. Availability of initiatives by healthcare organizations to raise awareness about pneumonia
  - 5.1.1.3. Growing inclination towards point-of-care testing (POCT) for pneumonia
- 5.1.2. Restraints
  - 5.1.2.1. High cost of comprehensive pneumonia testing
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing development of advanced rapid and accurate diagnostic tests for pneumonia
  - 5.1.3.2. Expanding potential for innovative biomarker-based tests
- 5.1.4. Challenges
  - 5.1.4.1. Limited access to testing in resource-limited settings
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Pneumonia Testing Market, by Type

6.1. Introduction
6.2. Instruments
6.3. Reagents & Consumables

7. Pneumonia Testing Market, by Method

7.1. Introduction
7.2. Immunodiagnostics
7.3. Molecular Diagnostics
7.4. Point of Care Testing

8. Pneumonia Testing Market, by Technology

8.1. Introduction
8.2. Enzyme Linked Immunosorbent Assay
8.3. Immunofluorescence
8.4. Immunohistochemistry
8.5. Polymerase Chain Reaction
8.6. Western Blot

9. Pneumonia Testing Market, by End-user

9.1. Introduction
9.2. Diagnostic Laboratories
9.3. Hospitals & Clinics

10. Americas Pneumonia Testing Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Pneumonia Testing Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Pneumonia Testing Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
- 14.1.1. Abbott Laboratories
- 14.1.2. Becton, Dickinson and Company
- 14.1.3. Bio-Rad Laboratories, Inc.
- 14.1.4. bioMerieux SA
- 14.1.5. Curetis GmbH
- 14.1.6. Danaher Corporation
- 14.1.7. DiaSorin S.p.A.
- 14.1.8. Eurofins Scientific SE
- 14.1.9. F. Hoffmann-La Roche Ltd
- 14.1.10. Hain Lifescience GmbH by Bruker Corporation
- 14.1.11. Hologic, Inc.
- 14.1.12. Intec Products, Inc.
- 14.1.13. Luminex Corporation
- 14.1.14. Meridian Bioscience, Inc.
- 14.1.15. OpGen Inc.
- 14.1.16. QIAGEN N.V.
- 14.1.17. Quest Diagnostics Incorporated
- 14.1.18. Quidel Corporation
- 14.1.19. Sekisui Diagnostics, LLC
- 14.1.20. Siemens Healthineers AG
- 14.1.21. Thermo Fisher Scientific Inc.
- 14.1.22. Trinity Biotech PLC
- 14.1.23. True Bearing Diagnostics, Inc.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing